Chester County News and Community Website
PHILADELPHIA, PA — GSK plc (NYSE: GSK) secured U.S. Food and Drug Administration approval for Hibsago, a hepatitis B treatment that achieved functional cure in 19% of eligible clinical trial …
FDA Approves GSK’s Hibsago for Chronic Hepatitis B Read More PHILADELPHIA, PA — The U.S. Food and Drug Administration has granted accelerated approval to GSK’s Jemperli as a standalone treatment for certain patients with locally advanced rectal cancer, creating an …
FDA Approves GSK’s Jemperli for Certain Rectal Cancer Patients Read More PHILADELPHIA, PA — GSK plc (NYSE: GSK) has enlisted actress Viola Davis for a national shingles awareness campaign targeting adults 50 and older, expanding the pharmaceutical company’s efforts to encourage …
GSK Enlists Viola Davis in National Shingles Awareness Campaign Read More
UPPER MERION TWP, PA — GSK will invest more than $800 million to expand its biopharmaceutical manufacturing and research operations in Montgomery County, creating more than 300 jobs over five …
GSK Commits Over $800 Million to Montgomery County Expansion Read More PHILADELPHIA, PA — GSK (LSE: GSK; NYSE: GSK) and Spero Therapeutics (Nasdaq: SPRO) said the U.S. Food and Drug Administration has approved Utebzi, the first oral carbapenem antibiotic for adults …
FDA Clears GSK Antibiotic for Drug-Resistant UTI Patients Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) launched a new phase of its Ask2BSure meningitis awareness campaign featuring actors Julie Bowen and Ty Burrell as the drugmaker intensifies outreach aimed …
GSK Expands Meningitis Campaign With Julie Bowen, Ty Burrell Read More PHILADELPHIA, PA — GSK plc (NYSE: GSK) said the U.S. Food and Drug Administration has expanded approval of its RSV vaccine AREXVY to include adults ages 18 to 49 who …
FDA Expands GSK RSV Vaccine Use to At-Risk Adults Ages 18–49 Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) announced new real-world effectiveness data for its RSV vaccine, AREXVY, showing an association with reduced RSV-related hospitalizations in adults 60 and older.
GSK Reports RSV Vaccine Data on Hospitalization Risk Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has awarded $2 million to 16 nonprofit organizations nationwide as part of its COiMMUNITY Initiative, intensifying efforts to improve immunization education, access, and …
GSK Backs Vaccine Push With $2M Grants as U.S. Immunization Gaps Loom Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has awarded nearly $1 million in grant funding to nonprofit organizations across the United States aimed at improving diagnosis, treatment, and long-term care …
GSK Awards Nearly $1M to Fuel Community Fight Against Lupus Nationwide Read More